(Q51455335)

English

Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase.

scientific article published on 2 June 2011

Statements

Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. (English)
0 references
0 references
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit